Back

Viking Therapeutics shares surge over 40% in two days on VK2735 data

Verifying
  • Viking Therapeutics reported positive weight-loss maintenance results for VK2735.
  • Over 40%: Viking shares gained that amount across two days after the announcement.
  • Viking plans to investigate oral maintenance dosing during the study's second phase.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.